Forging the Future of Healthcare Distribution: MedX's Strategic Alliances for 2026

In the rapidly evolving pharmaceutical landscape, the ability to connect high-quality manufacturing with expansive, efficient distribution is paramount. At MedX, our vision has always been to serve as the vital link between top-tier pharmaceutical brands and the pharmacies that serve patients nationwide. As we look toward 2026, we are proud to announce major strategic partnerships with Ampharco USA, TV.pharm (Aikya), and Rohto — agreements that significantly elevate our service offerings and market impact.

These partnerships reflect a profound level of trust from industry leaders and underscore MedX's evolution from a standard distributor to a comprehensive, strategic extension of the manufacturer.

Ampharco USA: Pioneering Direct Access to EU-GMP Quality

Quality assurance is the cornerstone of healthcare. Our expanded partnership with Ampharco USA—a top 50 brand on the MedX platform operating an EU-GMP certified manufacturing facility—marks a historic milestone. For the first time, Ampharco USA is launching an official flagship store directly on MedX.

Through this exclusive storefront, MedX will distribute the entirety of Ampharco USA's product portfolio. This direct-to-pharmacy model ensures that our network of healthcare providers receives not only guaranteed authentic, high-quality medications but also the most competitive pricing and exclusive promotional programs available in the market.

TV.pharm (Aikya): Accelerating Regional Growth and Long-Term Value

Our collaboration with TV.pharm (Aikya), another esteemed EU-GMP certified top 50 brand, exemplifies our capacity to execute targeted regional growth strategies. Recognizing the immense potential of the market, MedX and TV.pharm have structured dedicated, specialized contracts for the Northern and Southern regions, with a primary objective of aggressively accelerating market penetration in the North throughout 2026.

Furthermore, TV.pharm is increasing the supply of special control goods to MedX, ensuring that we can consistently meet the complex demands of our customers. This partnership is built on a foundation of deep, sustainable collaboration. MedX is committed to acting as the extended arm of Aikya, delivering their products to pharmacies nationwide while maintaining strict adherence to their pricing and promotional structures. Looking ahead, MedX and Aikya are actively developing long-term strategic initiatives, including exclusive distribution rights, OEM manufacturing, and joint brand development.

Rohto: Strategic Alignment for Brand Excellence

Sustainable growth requires continuous alignment and shared vision. Following a highly productive 2025 Business Review with Rohto, we have successfully formalized our joint Proposal for 2026.

This upcoming year will be characterized by a deep exchange of operational policies and a concerted effort to co-execute brand activation initiatives. By closely aligning our strategic objectives, MedX and Rohto are perfectly positioned to drive powerful brand development and capture new market opportunities together.

Building a Sustainable Healthcare Ecosystem

The strategic agreements with Ampharco USA, TV.pharm, and Rohto are more than just business contracts; they are the building blocks of a more resilient, accessible, and high-quality healthcare ecosystem in Vietnam. By integrating the manufacturing excellence of our partners with the expansive reach and digital capabilities of MedX, we are creating unparalleled value for pharmacies and, ultimately, the patients they serve.

MedX remains dedicated to fostering these deep, sustainable partnerships as we continue to lead the transformation of healthcare distribution.